BEHAVIOR OF N-METHYLATED ALLOPURINOLS AND RELATED 4-THIOXOPYRAZOLO (3,4-D) PYRIMIDINES TOWARDS BOVINE MILK XANTHINE OXIDASEBERGMANN F; FRANK A; GOVRIN H et al.1979; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1979; VOL. 570; NO 1; PP. 215-220; BIBL. 13 REF.Article

Development of patient-friendly preparations: Preparation of a new allopurinol mouthwash containing polyethylene(oxide) and carrageenanHANAWA, Takehisa; MASUDA, Nami; MOHRI, Kiminori et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 151-161, issn 0363-9045, 11 p.Article

Tumour lysis syndrome: new therapeutic strategies and classificationCAIRO, Mitchell S; BISHOP, Michael.British journal of haematology. 2004, Vol 127, Num 1, pp 3-11, issn 0007-1048, 9 p.Article

Pharmakogenetik : Neue kutane Arzneimittelnebenwirkunger = Pharmacogenetics : New cutaneous side effects of drugsMERK, H. F.Der Hautarzt. 2010, Vol 61, Num 8, pp 650-653, issn 0017-8470, 4 p.Article

In situ electrode modification for direct differential pulse polarography of 2,6-diaminopurine and its metabolite, 2,6-diamino-8-purinolSZURLEY, E; BRAJTER-TOTH, A.Analytica chimica acta. 1983, Vol 154, pp 323-327, issn 0003-2670Article

Detection of HLA-B^*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplificationKWOK, J; KWONG, K. M.British journal of dermatology (1951). 2013, Vol 168, Num 3, pp 526-532, issn 0007-0963, 7 p.Article

Intravenous Allopurinol in the Prevention and Treatment of Tumor Lysis SyndromeDUTCHER, Janice P.Seminars in oncology. 2001, Vol 28, Num 2, issn 0093-7754, 23 p., SUP5Serial Issue

Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinolHAMANAKA, H; MIZUTANI, H; NOUCHI, N et al.Clinical and experimental dermatology (Print). 1998, Vol 23, Num 1, pp 32-34, issn 0307-6938Article

A Case of Gingival Ulcer Thought to Be Caused by AllopurinolSATO, Chu; NOMURA, Joji; MATSUMURA, Yoshihiko et al.Journal of oral and maxillofacial surgery. 2009, Vol 67, Num 11, pp 2510-2513, issn 0278-2391, 4 p.Article

Allopurinol et aplasie médullaire = Allopurinol and bone marrow aplasiaLa Revue Prescrire. 2002, Vol 22, Num 232, issn 0247-7750, p. 669Article

Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radicalSPECTOR, T.Biochemical pharmacology. 1988, Vol 37, Num 2, pp 349-352, issn 0006-2952Article

Starting Dose Is a Risk Factor for Allopurinol Hypersensitivity Syndrome: A Proposed Safe Starting Dose of AllopurinolSTAMP, Lisa K; TAYLOR, William J; JONES, Peter B et al.Arthritis and rheumatism. 2012, Vol 64, Num 8, pp 2529-2536, issn 0004-3591, 8 p.Article

An unusual cutaneous reaction secondary to allopurinolRAYMOND, J. Z; GOLDMAN, H. M.Cutis (New York, NY). 1988, Vol 41, Num 5, pp 323-326, issn 0011-4162Article

Hipersensibilidad severa por ingesta de allopurinol: a propósito de dos casos = Toxicité induite par l'allopurinol = Severe toxicity following allopurinol intakeLLAMAS MARTIN, R; ONATE CUCHET, M. J; MESTRE BAUZA, F et al.Actas dermo-sifiliográficas (Ed. impresa). 1987, Vol 78, Num 7-8, pp 511-514, issn 0001-7310Article

Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction couplingAGARWAL, Amit; BANERJEE, Avik; BANERJEE, U. C et al.Critical reviews in biotechnology. 2011, Vol 31, Num 3, pp 264-280, issn 0738-8551, 17 p.Article

Tumor Lysis SyndromeRAJENDRAN, Aruna; BANSAL, Deepak; MARWAHA, R. K et al.Indian journal of pediatrics. 2013, Vol 80, Num 1, pp 50-54, issn 0019-5456, 5 p.Article

Linear angeordnete Ulzerationen mit zentralem Pfropf = Linear ulcers with central keratinous plugRÜGER, R; TREUDLER, R; PAASCH, U et al.Der Hautarzt. 2009, Vol 60, Num 1, pp 58-61, issn 0017-8470, 4 p.Article

Panzytopenie unter kombinierter Behandlung mit Azathioprin und Allopurinol = Panzytopenia from combination therapy with azathioprin and allopurinolSEIDEL, W.Zeitschrift für Rheumatologie (Print). 2004, Vol 63, Num 5, pp 425-427, issn 0340-1855, 3 p.Article

The development of allopurinolWAYNE RUNDLES, R.Archives of internal medicine (1960). 1985, Vol 145, Num 8, pp 1492-1503, issn 0003-9926Article

Determination of allopurinol by micelle-stabilised roomtemperature phosphorescence in real samplesPEREZ-RUIZ, Tomas; MARTINEZ-LOZANO, Carmen; TOMAS, Virginia et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 32, Num 2, pp 225-231, issn 0731-7085, 7 p.Article

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiencyHANDE, K. R; NOONE, R. M; STONE, W. J et al.The American journal of medicine. 1984, Vol 76, pp 47-56, issn 0002-9343Article

Impact of allopurinol use on urate concentration and cardiovascular outcomeLI WEI; MACKENZIE, Isla S; YANG CHEN et al.British journal of clinical pharmacology. 2011, Vol 71, Num 4, pp 600-607, issn 0306-5251, 8 p.Article

Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophreniaBUIE, Larry W; OERTEL, Maryann D; CALA, Suzanne O et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2200-2204, issn 1060-0280, 5 p.Article

Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans: ErratumKANG, H. R; JEE, Y. K; KIM, Y. S et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 8, issn 1744-6872, p. 652Article

Allopurinol in der Behandlung de kutanen Sarkoidose = Allopurinol in the treatment of cutaneous sarcoidosisPFAU, A; STOLZ, W; KARRER, S et al.Hautarzt. 1998, Vol 49, Num 3, pp 216-218, issn 0017-8470Article